Pathogenesis of systemic lupus erythematosus (original) (raw)
Pathogenesis of systemic lupus erythematosus
- C C Mok1,
- C S Lau2
- 1Department of Medicine and Geriatrics, Tuen Mun Hospital, Tsing Chung Koon Road, New Territories, Hong Kong
- 2Department of Medicine, Queen Mary Hospital, Hong Kong, SAR, China
- Correspondence to: Dr C C Mok, Department of Medicine and Geriatrics, Tuen Mun Hospital, Tsing Chung Koon Road, New Territories, Hong Kong; ccmok{at}netvigator.com
Abstract
The exact patho-aetiology of systemic lupus erythematosus (SLE) remains elusive. An extremely complicated and multifactorial interaction among various genetic and environmental factors is probably involved. Multiple genes contribute to disease susceptibility. The interaction of sex, hormonal milieu, and the hypothalamo–pituitary–adrenal axis modifies this susceptibility and the clinical expression of the disease. Defective immune regulatory mechanisms, such as the clearance of apoptotic cells and immune complexes, are important contributors to the development of SLE. The loss of immune tolerance, increased antigenic load, excess T cell help, defective B cell suppression, and the shifting of T helper 1 (Th1) to Th2 immune responses leads to B cell hyperactivity and the production of pathogenic autoantibodies. Finally, certain environmental factors are probably required to trigger the disease.
- aetiology
- pathogenesis
- genetic
- interaction
- autoimmune
- autoantibody
- APC, antigen presenting cell
- CD40L, CD40 ligand
- CRH, corticotrophin releasing hormone
- DHEA, dehydroepiandrosterone
- dsDNA, double stranded DNA
- FasL, Fas ligand
- GnRH, gonadotrophin releasing hormone
- HLA, human leucocyte antigen
- HPA, hypothalamo–pituitary–adrenal
- HRT, hormonal replacement therapy
- IL, interleukin
- LH, luteinising hormone
- MBP, mannose binding protein
- MHC, major histocompatibility complex
- NK, natural killer
- nRNP, nuclear ribonuclear protein
- OC, oral contraceptive
- PBMC, peripheral blood mononuclear cell
- SLE, systemic lupus erythematosus
- sm, Smith antigen
- snRPN, small nuclear ribonuclear protein
- Th1, T helper type 1
Statistics from Altmetric.com
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
- aetiology
- pathogenesis
- genetic
- interaction
- autoimmune
- autoantibody
- APC, antigen presenting cell
- CD40L, CD40 ligand
- CRH, corticotrophin releasing hormone
- DHEA, dehydroepiandrosterone
- dsDNA, double stranded DNA
- FasL, Fas ligand
- GnRH, gonadotrophin releasing hormone
- HLA, human leucocyte antigen
- HPA, hypothalamo–pituitary–adrenal
- HRT, hormonal replacement therapy
- IL, interleukin
- LH, luteinising hormone
- MBP, mannose binding protein
- MHC, major histocompatibility complex
- NK, natural killer
- nRNP, nuclear ribonuclear protein
- OC, oral contraceptive
- PBMC, peripheral blood mononuclear cell
- SLE, systemic lupus erythematosus
- sm, Smith antigen
- snRPN, small nuclear ribonuclear protein
- Th1, T helper type 1